Cargando…
Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
BACKGROUND: We investigated whether antiplatelet/anticoagulant (APAC) therapy can protect patients with type 2 diabetes mellitus (T2DM) from the development or progression of diabetic retinopathy (DR). METHODS: This is a retrospective cohort study using Longitudinal Health Insurance Database in Taiw...
Autores principales: | Jeng, Chi-Juei, Hsieh, Yi-Ting, Lin, Cheng-Li, Wang, I-Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932222/ https://www.ncbi.nlm.nih.gov/pubmed/35300625 http://dx.doi.org/10.1186/s12886-022-02323-z |
Ejemplares similares
-
Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression
por: Jeng, Chi-Juei, et al.
Publicado: (2016) -
Development of diabetic retinopathy after cataract surgery
por: Jeng, Chi-Juei, et al.
Publicado: (2018) -
Ubiquitin-proteasome system in diabetic retinopathy
por: Svikle, Zane, et al.
Publicado: (2022) -
Percutaneous Nephrolithotomy in Patients on Chronic Anticoagulant/Antiplatelet Therapy
por: Nerli, R B, et al.
Publicado: (2012) -
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)